Viridian Therapeutics, Inc. | Mid-cap | Energy

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 199.7M
Gross Profit 37.8M 18.91%
Operating Income 11.3M 5.63%
Net Income 5.2M 2.60%

Balance Sheet Metrics

Total Assets 2.3B
Total Liabilities 1.4B
Shareholders Equity 913.5M
Debt to Equity 1.56

Cash Flow Metrics

Operating Cash Flow 41.7M
Free Cash Flow 126.4M

Revenue & Profitability Trend

Viridian Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i1.0B1.1B927.4M1.1B886.7M
Cost of Goods Sold i742.6M817.4M654.9M853.2M726.5M
Gross Profit i290.0M258.4M272.5M209.8M160.2M
Gross Margin % i28.1%24.0%29.4%19.7%18.1%
Operating Expenses
Research & Development i15.2M26.1M19.0M17.0M18.6M
Selling, General & Administrative i102.3M111.9M97.8M92.8M100.4M
Other Operating Expenses i----214.5M
Total Operating Expenses i117.5M138.0M116.8M109.8M333.5M
Operating Income i172.5M120.4M155.7M100.0M41.2M
Operating Margin % i16.7%11.2%16.8%9.4%4.6%
Non-Operating Items
Interest Income i10.5M8.0M1.7M1.0M2.2M
Interest Expense i93.3M103.3M100.2M121.5M136.3M
Other Non-Operating Income-----
Pre-tax Income i42.7M19.9M83.5M-186.1M-346.8M
Income Tax i11.4M14.0M17.2M-4.4M29.3M
Effective Tax Rate % i26.7%70.4%20.6%0.0%0.0%
Net Income i43.3M16.2M43.3M-180.0M-436.8M
Net Margin % i4.2%1.5%4.7%-16.9%-49.3%
Key Metrics
EBITDA i262.1M200.4M237.1M267.5M177.4M
EPS (Basic) i€6.97€2.00€6.00€-25.00€-62.00
EPS (Diluted) i€6.93€2.00€6.00€-25.00€-62.00
Basic Shares Outstanding i60954767477936741084274049977396810
Diluted Shares Outstanding i60954767477936741084274049977396810

Income Statement Trend

Viridian Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i213.8M282.8M250.5M281.7M385.4M
Short-term Investments i341.0K-2.9M4.1M14.8M
Accounts Receivable i227.8M245.6M253.6M305.1M263.7M
Inventory i139.2M212.9M257.2M197.3M237.8M
Other Current Assets-170.5K---800.0K
Total Current Assets i789.5M973.7M1.0B1.0B1.2B
Non-Current Assets
Property, Plant & Equipment i293.0M358.7M333.4M110.2M132.3M
Goodwill i2.3B2.8B2.7B2.7B3.0B
Intangible Assets i456.3M579.7M554.2M520.7M639.2M
Long-term Investments-----
Other Non-Current Assets7.7M6.9M8.3M--
Total Non-Current Assets i1.6B1.9B1.9B1.9B2.1B
Total Assets i2.4B2.9B2.9B2.9B3.4B
Liabilities
Current Liabilities
Accounts Payable i103.1M86.4M92.0M76.4M96.7M
Short-term Debt i48.5M58.0M60.4M90.3M58.8M
Current Portion of Long-term Debt-----
Other Current Liabilities8.2M30.6M37.9M28.1M19.0M
Total Current Liabilities i432.2M550.3M554.3M585.2M716.9M
Non-Current Liabilities
Long-term Debt i993.6M1.2B1.2B1.2B1.3B
Deferred Tax Liabilities i15.7M24.3M18.7M14.1M16.3M
Other Non-Current Liabilities1.4M4.3M18.4M32.8M44.4M
Total Non-Current Liabilities i1.0B1.3B1.3B1.3B1.5B
Total Liabilities i1.5B1.9B1.8B1.9B2.2B
Equity
Common Stock i7.4M8.7M8.7M8.7M8.7M
Retained Earnings i883.5M-967.9M570.0M-480.6M
Treasury Stock i17.1M20.1M20.1M20.1M20.1M
Other Equity-----
Total Shareholders Equity i957.1M1.1B1.1B1.0B1.2B
Key Metrics
Total Debt i1.0B1.3B1.2B1.3B1.4B
Working Capital i357.3M423.4M462.6M457.5M514.3M

Balance Sheet Composition

Viridian Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i30.8M3.9M47.8M-181.6M-407.9M
Depreciation & Amortization i-----
Stock-Based Compensation i2.9M2.8M3.0M-1.8M4.0M
Working Capital Changes i-75.0M60.1M-68.9M-61.5M-33.6M
Operating Cash Flow i41.3M167.3M80.0M-82.0M-264.1M
Investing Activities
Capital Expenditures i-22.2M-60.5M40.5M-54.9M-63.6M
Acquisitions i-----
Investment Purchases i-7.0M-7.1M-38.9M-5.2M-400.0K
Investment Sales i06.2M4.9M89.3M13.4M
Investing Cash Flow i-29.3M-61.4M6.4M29.5M-37.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i85.2K23.9M12.3M1.2B0
Debt Repayment i-50.6M-1.8M-100.0K-1.2B-5.2M
Financing Cash Flow i-50.5M22.2M12.6M-67.2M-5.1M
Free Cash Flow i146.4M176.3M85.7M109.8M-38.8M
Net Change in Cash i-38.6M128.1M99.0M-119.7M-306.4M

Cash Flow Trend

Viridian Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 41.32
Forward P/E 5.61
Price to Book 0.41
Price to Sales 0.37
PEG Ratio 5.61

Profitability Ratios

Profit Margin -0.36%
Operating Margin 5.81%
Return on Equity -0.33%
Return on Assets 4.06%

Financial Health

Current Ratio 1.46
Debt to Equity 108.09
Beta 1.39

Per Share Data

EPS (TTM) €-0.56
Book Value per Share €144.08
Revenue per Share €158.90

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
viri432.6M41.320.41-0.33%-0.36%108.09
CGG SA 42.6B4.3243.461.21%24.02%1.23
Technip Energies 7.4B18.793.4419.56%5.41%45.62
Gaztransport Et 5.8B16.2911.6277.67%48.61%3.10
Dolfines S.A 4.4M4.061.0527.43%12.61%33.76
TotalEnergies SE 116.5B11.160.9910.92%6.83%53.01

Financial data is updated regularly. All figures are in the company's reporting currency.